Literature DB >> 14617349

The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells.

Rebecca Khor1, Lisa J McElroy, Gary R Whittaker.   

Abstract

Influenza virus enters cells by endocytosis, and requires the low pH of the late endosome for successful infection. Here, we investigated the requirements for sorting into the multivesicular body pathway of endocytosis. We show that treatment of host cells with the proteasome inhibitors MG132 and lactacystin directly affects the early stages of virus replication. Unlike other viruses, such as retroviruses, influenza virus budding was not affected. The requirement for proteasome function was not shared by two other pH-dependent viruses: Semliki Forest virus and vesicular stomatitis virus. With MG132 treatment, incoming influenza viruses were retained in endosomes that partially colocalized with mannose 6-phosphate receptor, but not with classical markers of early or late endosomes. Colocalization was also observed with Rme-1, which is part of the recycling pathway of endocytosis. In addition, influenza virus entry was dependent on the vacuolar protein sorting pathway, as over-expression of dominant-negative hVPS4 caused arrest of viruses in endosome-like populations that partially colocalized with the hVPS4 protein. Overall, we conclude that influenza virus selectively requires the ubiquitin/vacuolar protein sorting pathway for entry into host cells, and that it must communicate with a specific cellular machinery for intracellular sorting during the initial phase of virus infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617349     DOI: 10.1046/j.1398-9219.2003.0140.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  58 in total

1.  Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication.

Authors:  Tsai-Ling Liao; Chung-Yi Wu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

2.  Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 3.  Endocytosis of influenza viruses.

Authors:  Melike Lakadamyali; Michael J Rust; Xiaowei Zhuang
Journal:  Microbes Infect       Date:  2004-08       Impact factor: 2.700

4.  Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus.

Authors:  Anthony P Schmitt; George P Leser; Eiji Morita; Wesley I Sundquist; Robert A Lamb
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step.

Authors:  Mark G Delboy; Devin G Roller; Anthony V Nicola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

6.  Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes.

Authors:  P S Satheshkumar; Luis C Anton; Patrick Sanz; Bernard Moss
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  Rotavirus replication requires a functional proteasome for effective assembly of viroplasms.

Authors:  R Contin; F Arnoldi; M Mano; O R Burrone
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

Review 8.  Endosome maturation.

Authors:  Jatta Huotari; Ari Helenius
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

9.  A capsid-encoded PPxY-motif facilitates adenovirus entry.

Authors:  Harald Wodrich; Daniel Henaff; Baptist Jammart; Carolina Segura-Morales; Sigrid Seelmeir; Olivier Coux; Zsolt Ruzsics; Christopher M Wiethoff; Eric J Kremer
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

Review 10.  Influenza virus morphogenesis and budding.

Authors:  Debi P Nayak; Rilwan A Balogun; Hiroshi Yamada; Z Hong Zhou; Subrata Barman
Journal:  Virus Res       Date:  2009-05-27       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.